What to Anticipate in Colgate-Palmolive’s Upcoming Earnings Report

Colgate-Palmolive Company (CL) is a global consumer products company with a market capitalization of $63.7 billion. The company manufactures and sells a variety of products including oral care, personal care, home care, and pet nutrition items in both domestic and international markets. Colgate-Palmolive operates through two main segments: Oral, Personal, and Home Care, as well as Pet Nutrition. Their products are available through a wide range of trusted brands and distribution channels, catering to both consumers and professionals alike.

As Colgate-Palmolive prepares to announce its fiscal Q4 2025 results, analysts are predicting an adjusted earnings per share (EPS) of $0.92, reflecting a 1.1% increase from the previous year’s $0.91. The company has consistently outperformed Wall Street’s earnings expectations in the past four quarters. Looking ahead to fiscal 2025, analysts are projecting an adjusted EPS of $3.66, a 1.7% growth from fiscal 2024’s $3.60. Additionally, the adjusted EPS is expected to rise by 5.2% year-over-year to $3.85 in fiscal 2026.

Despite this positive outlook, Colgate-Palmolive’s shares have experienced a decline of nearly 13% over the last 52 weeks, underperforming compared to the S&P 500 Index’s 16.4% return and the State Street Consumer Staples Select Sector SPDR ETF’s slight decrease in the same period.

Following the company’s financial report for Q3 2025, which showcased higher net sales of $5.13 billion and an adjusted EPS of $0.91, Colgate-Palmolive’s stock saw a slight increase on October 31. The company continues to hold a prominent market share in toothpaste at 41.2% and manual toothbrushes at 32.4%, despite experiencing modest organic sales growth.

Analysts have expressed a cautiously optimistic sentiment towards CL stock, with an overall “Moderate Buy” rating. Out of 21 analysts covering the stock, eight recommend a “Strong Buy,” three suggest a “Moderate Buy,” eight recommend holding, and two advise a “Strong Buy.” The average analyst price target for Colgate-Palmolive stands at $86.81, indicating a potential upside of 9.9% from the current trading levels.

It is important to note that the information and data presented in this article are for informational purposes only.